Fundz

Who to call at Rapport Therapeutics, Inc., and when

Fundz watches for the moments Rapport Therapeutics, Inc. starts buying, and tells you who to reach.

  • An alert the day Rapport Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rapport Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rapport Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

Rapport Therapeutics, Inc.

The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.

rapport.cloud
Filed: Oct 30, 2026Boston, MassachusettsCIK: 0002012593Software
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Rapport Therapeutics completed an underwritten public offering of 8.3 million shares at $21.00 per share, raising approximately $175 million in gross proceeds, with underwriters exercising their full over-allotment option. This capital infusion provides financial resources to support the company's operations and strategic growth objectives.

Quick answer

Rapport Therapeutics, Inc. filed a Form 8-K with the SEC on October 30, 2026 under Item 1.01 (Entry into Material Agreement). Rapport Therapeutics completed an underwritten public offering of 8.3 million shares at $21.00 per share, raising approximately $175 million in gross proceeds, with underwriters exercising their full over-allotment option.

What did Rapport Therapeutics, Inc. disclose in its 8-K filed October 30, 2026?
Rapport Therapeutics completed an underwritten public offering of 8.3 million shares at $21.00 per share, raising approximately $175 million in gross proceeds, with underwriters exercising their full over-allotment option. This capital infusion provides financial resources to support the company's operations and strategic growth objectives.
What does 8-K Item 1.01 (Entry into Material Agreement) mean?
The company signed a major contract or deal. Companies generally must file it within four business days of the event.
Which other companies filed an 8-K Item 1.01 around the same time?
OpenWorld, Inc. (October 30, 2026) also filed an Item 1.01 8-K within a week of Rapport Therapeutics, Inc.
Where can I read the original Rapport Therapeutics, Inc. filing?
The original filing is on SEC EDGAR (CIK 0002012593), accession number 0001193125-26-441851.

Source: Fundz verified event record.

Other companies that filed an 8-K Item 1.01 (Entry into Material Agreement) the same week

Analyzed filings with the same item number within 7 days, from SEC EDGAR via Fundz.

  • OpenWorld, Inc. (October 30, 2026): OpenWorld appointed Patrick Kim as CEO of Blocksight effective October 27, 2026, following the company's merger.

Key Takeaways

Rapport raised approximately $175 million gross from the primary offering (8.3M shares × $21.00) plus additional proceeds from the full exercise of the 1.4M share over-allotment option

The offering included 1.2 million pre-funded warrants with a nominal $0.001 exercise price, providing immediate dilution and potential for additional capital upon exercise

2 more takeaways

Related Filings (1)

1 more filing from Rapport Therapeutics, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateOct 30, 2026
Item1.01
CategoryMaterial Agreement
CIK0002012593
Accession #0001193125-26-441851
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
stock offering

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings

Rapport Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.